SCHEMBL25645650

SCHEMBL25645650

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5ccc6c(c5)sc5ccccc56)c4)nc(-c4ccc5c(c4)oc4ccccc45)n3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.39
PLA2G4A P47712 3/20 0.39
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
HCRTR1 O43613 1/20 0.37
PLA2G10 O15496 1/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
RAB9A P51151 2/20 0.36
AHR P35869 2/20 0.36
LIMK1 P53667 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
PIK3CA P42336 1/20 0.35
PI4KA P42356 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21029001 1.00 PLA2G2A (0.39) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL21028998 1.00 PLA2G2A (0.39) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL25645706 1.00 PLA2G2A (0.39) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL25852096 1.00 PLA2G2A (0.39) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL25852034 1.00 PLA2G2A (0.39) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL25645714 1.00 PLA2G2A (0.39) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL21029000 1.00 PLA2G2A (0.39) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL23913827 0.99 PLA2G2A (0.39) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL21028996 0.99 HCRTR1 (0.38) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL25645710 0.99 HCRTR1 (0.38) PLA2G2APLA2G4AMMP12MMP13HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, CYP1A1, CYP1B1 PLA2G2A 3909/4885PLA2G4A 3952/4885MMP12 4473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.